immediate side effects of semaglutide Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Semaglutide Side Effects: Common vs

Additionally, they reduce cravings by slowing digestion, extending satiety and making it easier to manage your appetite

Product: Hanson Pharmaceutical's GLP-1/GIP dual target weight loss innovative drug, Olepotide, has been accepted for application and marketing for weight loss indications On June 4, 2026, Hanson Pharmaceutical Group Co., Ltd

However, further evidence is needed to determine its overall impact and future role in weight management

Having these results first means you and your doctor can spot new changes down the roadan advantage if you start feeling off or want to know exactly how your treatment is working

Some people, particularly those still in the titration phase or those sensitive to gastrointestinal effects, report mild increases in nausea

Semaglutide is a GLP-1 receptor agonist, meaning it mimics the bodys own glucagon-like peptide-1 hormone, which helps regulate appetite and insulin secretion